Kathmere Capital Management’s Sanofi SNY Stock Holding History

Kathmere Capital Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$211K	Sell	4,937 -313	-6%	-$14K	0.01%	621
2026 Q1	$253K	Buy	5,250 +318	+6%	+$14.8K	0.02%	516
2025 Q4	$239K	Buy	+4,932	New	+$244K	0.02%	475
2025 Q3	–	Sell	-4,578	Closed	-$221K	–	549
2025 Q2	$221K	Sell	4,578 -47	-1%	-$2.4K	0.02%	432
2025 Q1	$257K	Buy	+4,625	New	+$250K	0.02%	359
2021 Q1	–	Sell	-500	Closed	-$24K	–	361
2020 Q4	$24K	Buy	+500	New	+$24.7K	0.01%	278

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Kathmere Capital Management's SNY Position: Q2 2026 in Review

Kathmere Capital Management reduced its Sanofi (SNY) stake by 6% in Q2 2026, selling an estimated $14K and leaving 4,937 shares worth $211K. The position accounts for 0.01% of the portfolio, ranked #621.

Kathmere Capital Management first reported a position in SNY in Q4 2020 and has held it in 6 quarters since. The position peaked at $257K in Q1 2025. 717 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Kathmere Capital Management held 4,937 shares of Sanofi worth $211K as of Q2 2026.
Kathmere Capital Management sold 313 Sanofi shares in Q2 2026, an estimated $14K.
Sanofi made up 0.01% of Kathmere Capital Management's portfolio in Q2 2026, its #621 holding.
Kathmere Capital Management first reported a position in Sanofi in Q4 2020 and has held it in 6 quarters since.
Kathmere Capital Management's Sanofi position peaked at $257K in Q1 2025.
717 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Kathmere Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.